Who Owns Annovis Bio Stock?
NYSE: ANVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 27.86%
- Held by insiders
- 11.79%
- Institutional holders
- 70
- Institutions 27.9%
- Insiders 11.8%
- Public and other 60.4%
Who owns Annovis Bio stock?
Institutional investors own about 27.9% of Annovis Bio's shares, spread across 70 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 11.79% of ANVS.
The largest institutional holders are Empery Asset Management, LP (5.63%), Marshall Wace LLP (4.32%) and Vanguard Capital Management LLC (3.86%). Together, the top 10 institutions control 23.0% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their ANVS positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ANVS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Empery Asset Management, LP | 2.40M | 5.63% | +100.0% |
| Marshall Wace LLP | 1.84M | 4.32% | +55.1% |
| Vanguard Capital Management LLC | 1.65M | 3.86% | +88.8% |
| Tudor Investment Corp Et Al | 1.36M | 3.18% | +100.0% |
| Renaissance Technologies, LLC | 1.00M | 2.35% | +188.3% |
| Two Sigma Investments, LP | 579.57K | 1.36% | -7.7% |
| Geode Capital Management, LLC | 283.82K | 0.67% | +14.7% |
| Blackrock Inc. | 249.86K | 0.59% | +79.1% |
| Citadel Advisors Llc | 243.68K | 0.57% | +100.0% |
| Vanguard Fiduciary Trust Co | 177.53K | 0.42% | +34.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ANVS
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.22M | 2.86% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 393.89K | 0.92% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 153.14K | 0.36% |
| iShares Trust-iShares Micro-Cap ETF | 102.65K | 0.24% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 45.69K | 0.11% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 34.46K | 0.08% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 20.99K | 0.05% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 12.72K | 0.03% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 6.99K | 0.02% |
| John Hancock Variable Insurance Trust-Total Stock Market Index Trust | 557 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Annovis Bio?
Empery Asset Management, LP is the largest institutional shareholder of ANVS, owning 5.63% of shares outstanding (2.40M shares) as of its latest 13F filing.
What percentage of Annovis Bio is owned by institutions?
Institutions own about 27.9% of ANVS shares and 31.6% of the public float.
How much of Annovis Bio do insiders own?
Insiders, such as officers and directors, own about 11.79% of ANVS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.